SERPINB2 and neoplasm: The four therapeutic experiments with s.c. xenografts carried out in vivo were designed to evaluate the antitumour activity and anti-metastatic effect of 213Bi-PAI2 after administration at different stages of tumour growth and to optimise the dosage regimen.